In some patients, acute respiratory distress syndrome (ARDS) leads to life-threatening
refractory hypoxemia developing. Physicians may consider hypoxemic rescue therapies in …

In 1987, nitric oxide (NO) was identified by two independent groups51, 77 as the endothelial
derived relaxing factor, igniting an explosion of research that led to the naming of NO as the …

Introduction More than 20 years have passed since we reported our results of treating
patients with the acute respiratory distress syndrome (ARDS) with inhaled nitric oxide (iNO) …

This pilot randomized controlled clinical trial of patients with ARDS was implemented to
study the impact of inhaled nitric oxide (inhNO) on lung function, morbidity, and mortality …

Objective: Treatment with inhaled nitric oxide improves oxygenation but not survival in
mechanically ventilated patients with acute respiratory distress syndrome, but the effect may …

The acute respiratory distress syndrome (ARDS) is characterized by a maldistribution of
pulmonary blood flow towards non-ventilated atelectatic lung areas being the main reason …

Effects of inhaled nitric oxide in patients with acute respi... : Critical Care Medicine Effects of
inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a …

Fifteen years ago the presence of nitric oxide (NO) in biologic systems was virtually
unknown. Since then, physiologic roles of NO have been found for nearly every part of the …

BACKGROUND: Acute hypoxemic respiratory failure, defined as acute lung injury and acute
respiratory distress syndrome, are critical conditions associated with frequent mortality and …

Background: Inhaled nitric oxide (INO) can improve hypoxemia and reduce pulmonary
hypertension, but there is a wide range of response to INO. Objectives: The aim of this study …